{"schema_version":"secwatch.filing_event.v1","accession":"0000899923-26-000062","form_type":"8-K","ticker":"MYGN","cik":"0000899923","company_name":"MYRIAD GENETICS INC","filed_at":"2026-06-23T12:32:15+00:00","discovered_at":"2026-06-23T12:35:00.555249+00:00","generated_at":"2026-06-23T12:35:18.769689+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Myriad Genetics director Daniel M. Skovronsky resigns effective June 17, 2026","bullets":["Daniel M. Skovronsky resigned from Myriad Genetics board effective June 17, 2026.","Resignation was not due to any disagreement with the company or its operations.","Myriad Genetics (MYGN) filed Form 8-K on June 23, 2026 to report the departure.","Skovronsky served as a director prior to resignation."],"urls":{"canonical":"https://secwatch.observer/filing/0000899923-26-000062","json":"https://secwatch.observer/filing/0000899923-26-000062.json","markdown":"https://secwatch.observer/filing/0000899923-26-000062.md","text":"https://secwatch.observer/filing/0000899923-26-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/899923/000089992326000062/0000899923-26-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899923/000089992326000062/mygn-20260617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T12:35:18.769689+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}